Adi Heller

Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC patients (pts) treated with chemotherapy +/- erlotinib (TALENT)

U. Gatzemeier, Adi Heller, Dorothee Foernzler et al. · Journal of Clinical Oncology · 2005 · 41 citations

Pathology, Chemotherapy +/- Erlotinib, Tumor Biology +17

Expression of a PKR Dominant-Negative Mutant in Myogenic Cells Interferes with the Myogenic Process

Samuel Salzberg, Shlomit Vilchik, Shenhav Cohen et al. · Experimental Cell Research · 2000 · 24 citations

Signal Transduction, Developmental Biology, Molecular Physiology +11

Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells

Yael Segev, Rivka Ofir, Samuel Salzberg et al. · Journal of Virology · 1995 · 19 citations · Full text

Viral Replication, Viral Pathogenesis, Immunology +16

Effect of interferon on human cells releasing oncornaviruses: An assay for human interferon

Samuel Salzberg, Adi Heller, M. Aboud et al. · Virology · 1979 · 17 citations

Molecular Virology, Human Cells, Viral Pathogenesis +8

Hybrid silica nanoparticles traceable by fluorescence and FT-IR spectroscopy: preparation, characterization and preliminary biological studies

Maria Alesker, Adi Heller, Zvi Malik et al. · Journal of Materials Chemistry · 2011 · 12 citations

Nanoparticles, Engineering, Metal Nanoparticles +17